{"id":10548,"date":"2026-03-12T09:49:51","date_gmt":"2026-03-12T13:49:51","guid":{"rendered":"https:\/\/www.rigicon.com\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\/"},"modified":"2026-03-12T09:49:51","modified_gmt":"2026-03-12T13:49:51","slug":"survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de","status":"publish","type":"clinical-evidence","link":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\/","title":{"rendered":"Revisionsfreies \u00dcberleben der neuen Rigicon Infla10 dreiteiligen inflatbaren Penisprothese ist vergleichbar mit Vorg\u00e4ngerger\u00e4ten"},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","tags":[],"ce_category":[226],"ce_product":[256],"class_list":["post-10548","clinical-evidence","type-clinical-evidence","status-publish","hentry","ce_category-klinische-ergebnisstudien-de","ce_product-infla10-de"],"acf":{"ce_paper_title":"","ce_year":2023,"ce_journal":"Gold Journal","ce_doi":"https:\/\/doi.org\/10.1016\/j.urology.2023.06.031","ce_summary":"Diese Studie analysierte 535 Rigicon Infla10 Implantate aus 15 L\u00e4ndern zur Bewertung der Reoperationsraten. Das 3-Jahres-revisionsfreie \u00dcberleben betrug 94%, was eine vergleichbare Leistung zu etablierten IPPs zeigt. Produkt: Infla10.","ce_authors":"Steven K. Wilson, Hodo Haxhimolla, Boon Kua, Gerard Testa, Christopher Love, Mariano Rossello, Alejandro Carvajal, William Lynch, Muhammed A.M. Hammad, Martin Gross","ce_objective":"Bewertung der Revisionschirurgieraten und des Ger\u00e4te\u00fcberlebens der Rigicon Infla10 inflatbaren Penisprothese in einer globalen Kohorte.","ce_key_findings":"Unter 535 Patienten ben\u00f6tigten nur 3,5% eine Revision, haupts\u00e4chlich wegen mechanischen Versagens (2,24%). Die 3-Jahres-revisionsfreie \u00dcberlebensrate betrug 94%, vergleichbar mit Wettbewerber-IPPs. Mechanische Ausf\u00e4lle waren prim\u00e4r auf Reservoirschlauchleckagen zur\u00fcckzuf\u00fchren.","ce_conclusion":"Die Rigicon Infla10 zeigt ein hohes Ger\u00e4te\u00fcberleben und niedrige Revisionsraten, die mit denen etablierter Ger\u00e4te \u00fcbereinstimmen und ihre Sicherheit und Haltbarkeit best\u00e4tigen.","ce_clinical_relevance":"Die Ergebnisse unterst\u00fctzen die Rigicon Infla10 als zuverl\u00e4ssige und sichere Option f\u00fcr ED-Patienten und geben Klinikern Sicherheit hinsichtlich der revisionsfreien Haltbarkeit \u00fcber einen 3-Jahres-Zeitraum.","ce_pdf":null,"ce_logos":null,"ce_featured":true,"ce_keywords":"Infla10, Penisprothese, inflatbares Implantat, erektile Dysfunktion, Ger\u00e4te\u00fcberleben, Revisionsrate, mechanisches Versagen, Urologie"},"yoast_head":"\nRevisionsfreies \u00dcberleben der neuen Rigicon... - Rigicon\u00ae<\/title>\n<meta name=\"description\" content=\"Diese Studie analysierte 535 Rigicon Infla10 Implantate aus 15 L\u00e4ndern zur Bewertung der Reoperationsraten. Das 3-Jahres-revisionsfreie...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rigicon.com\/de\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revisionsfreies \u00dcberleben der neuen Rigicon Infla10 dreiteiligen inflatbaren Penisprothese ist vergleichbar mit Vorg\u00e4ngerger\u00e4ten | Peer-Reviewed Research\" \/>\n<meta property=\"og:description\" content=\"Diese Studie analysierte 535 Rigicon Infla10 Implantate aus 15 L\u00e4ndern zur Bewertung der Reoperationsraten. Das 3-Jahres-revisionsfreie \u00dcberleben betrug 94%, was eine vergleichbare Leistung zu etablierten IPPs zeigt. Produkt: Infla10.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rigicon.com\/de\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\/\" \/>\n<meta property=\"og:site_name\" content=\"Rigicon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rigiconurology\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/04\/header-d.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"718\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@rigiconurology\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/clinical-evidence\\\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/clinical-evidence\\\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\\\/\",\"name\":\"Revisionsfreies \u00dcberleben der neuen Rigicon... - Rigicon\u00ae\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/#website\"},\"datePublished\":\"2026-03-12T13:49:51+00:00\",\"description\":\"Diese Studie analysierte 535 Rigicon Infla10 Implantate aus 15 L\u00e4ndern zur Bewertung der Reoperationsraten. Das 3-Jahres-revisionsfreie...\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/clinical-evidence\\\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\\\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rigicon.com\\\/de\\\/clinical-evidence\\\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/clinical-evidence\\\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Klinische Evidenz\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/clinical-evidence\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Revisionsfreies \u00dcberleben der neuen Rigicon Infla10 dreiteiligen inflatbaren Penisprothese ist vergleichbar mit Vorg\u00e4ngerger\u00e4ten\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/\",\"name\":\"Rigicon\",\"description\":\"Innovative Urological Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/#organization\"},\"alternateName\":\"Innovative Urological Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/#organization\",\"name\":\"Rigicon, Inc.\",\"alternateName\":\"Innovative Urological Solutions\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"width\":512,\"height\":512,\"caption\":\"Rigicon, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/x.com\\\/rigiconurology\",\"https:\\\/\\\/www.instagram.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@Rigicon\\\/podcasts\",\"https:\\\/\\\/www.youtube.com\\\/Rigicon\",\"https:\\\/\\\/www.threads.net\\\/@rigiconurology\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rigicon\\\/\"],\"description\":\"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.\",\"email\":\"operations@rigicon.com\",\"telephone\":\"+1 (888) 202-9790\",\"legalName\":\"Rigicon, Inc.\",\"vatID\":\"81-3545645\",\"taxID\":\"81-3545645\",\"duns\":\"045247683\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Revisionsfreies \u00dcberleben der neuen Rigicon... - Rigicon\u00ae","description":"Diese Studie analysierte 535 Rigicon Infla10 Implantate aus 15 L\u00e4ndern zur Bewertung der Reoperationsraten. Das 3-Jahres-revisionsfreie...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\/","og_locale":"de_DE","og_type":"article","og_title":"Revisionsfreies \u00dcberleben der neuen Rigicon Infla10 dreiteiligen inflatbaren Penisprothese ist vergleichbar mit Vorg\u00e4ngerger\u00e4ten | Peer-Reviewed Research","og_description":"Diese Studie analysierte 535 Rigicon Infla10 Implantate aus 15 L\u00e4ndern zur Bewertung der Reoperationsraten. Das 3-Jahres-revisionsfreie \u00dcberleben betrug 94%, was eine vergleichbare Leistung zu etablierten IPPs zeigt. Produkt: Infla10.","og_url":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\/","og_site_name":"Rigicon","article_publisher":"https:\/\/www.facebook.com\/rigiconurology\/","og_image":[{"width":1440,"height":718,"url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/04\/header-d.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@rigiconurology","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\/","url":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\/","name":"Revisionsfreies \u00dcberleben der neuen Rigicon... - Rigicon\u00ae","isPartOf":{"@id":"https:\/\/www.rigicon.com\/de\/#website"},"datePublished":"2026-03-12T13:49:51+00:00","description":"Diese Studie analysierte 535 Rigicon Infla10 Implantate aus 15 L\u00e4ndern zur Bewertung der Reoperationsraten. Das 3-Jahres-revisionsfreie...","breadcrumb":{"@id":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rigicon.com\/de\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-de\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.rigicon.com\/de\/"},{"@type":"ListItem","position":2,"name":"Klinische Evidenz","item":"https:\/\/www.rigicon.com\/de\/clinical-evidence\/"},{"@type":"ListItem","position":3,"name":"Revisionsfreies \u00dcberleben der neuen Rigicon Infla10 dreiteiligen inflatbaren Penisprothese ist vergleichbar mit Vorg\u00e4ngerger\u00e4ten"}]},{"@type":"WebSite","@id":"https:\/\/www.rigicon.com\/de\/#website","url":"https:\/\/www.rigicon.com\/de\/","name":"Rigicon","description":"Innovative Urological Solutions","publisher":{"@id":"https:\/\/www.rigicon.com\/de\/#organization"},"alternateName":"Innovative Urological Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rigicon.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/www.rigicon.com\/de\/#organization","name":"Rigicon, Inc.","alternateName":"Innovative Urological Solutions","url":"https:\/\/www.rigicon.com\/de\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.rigicon.com\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","width":512,"height":512,"caption":"Rigicon, Inc."},"image":{"@id":"https:\/\/www.rigicon.com\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rigiconurology\/","https:\/\/x.com\/rigiconurology","https:\/\/www.instagram.com\/rigiconurology\/","https:\/\/www.youtube.com\/@Rigicon\/podcasts","https:\/\/www.youtube.com\/Rigicon","https:\/\/www.threads.net\/@rigiconurology","https:\/\/www.linkedin.com\/company\/rigicon\/"],"description":"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.","email":"operations@rigicon.com","telephone":"+1 (888) 202-9790","legalName":"Rigicon, Inc.","vatID":"81-3545645","taxID":"81-3545645","duns":"045247683"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/clinical-evidence\/10548","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/clinical-evidence"}],"about":[{"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/types\/clinical-evidence"}],"wp:attachment":[{"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/media?parent=10548"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/tags?post=10548"},{"taxonomy":"ce_category","embeddable":true,"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/ce_category?post=10548"},{"taxonomy":"ce_product","embeddable":true,"href":"https:\/\/www.rigicon.com\/de\/wp-json\/wp\/v2\/ce_product?post=10548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}